GlassScriptPhysician profile
Jefferson M Burroughs
NPI 1740289453
$4,889.01
in general payments reported to CMS, 2019-2025
35 companies · $50.66 in 2025
The $50.66 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,708 · 2020: $684 · 2021: $1,203 · 2022: $742 · 2023: $343 · 2024: $158 · 2025: $50.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $660.17 | 2019-2022 | |
| Bardy Diagnostics, INC. | $480.00 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $441.43 | 2019-2022 | |
| Medtronic Vascular, INC. | $433.89 | 2019-2020 | |
| Amgen INC. | $432.70 | 2019-2022 | |
| Medtronic, INC. | $410.68 | 2021-2022 | |
| Biosense Webster, INC. | $401.45 | 2021-2025 | Carto 3 |
| Vital Connect, INC | $213.93 | 2023-2024 | Vitalpatch Rtm |
| Abbott Laboratories | $209.34 | 2020-2023 | Ensite Precision |
| Novartis Pharmaceuticals Corporation | $171.25 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.07 | 2021-2023 | Jardiance |
| Cardiva Medical, INC. | $118.50 | 2021-2024 | Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $106.64 | 2019-2023 | |
| Tosoh Bioscience, INC. | $95.00 | 2019 | |
| Edwards Lifesciences Corporation | $72.44 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $48.18 | 2019-2020 | |
| Novo Nordisk INC | $37.35 | 2019 | |
| Cvrx, INC. | $34.85 | 2021-2023 | Barostim Neo System |
| Daiichi Sankyo INC. | $34.43 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $29.78 | 2019 | |
| Vifor Pharma, INC. | $29.34 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.42 | 2021-2022 | |
| Amarin Pharma, INC. | $26.65 | 2019 | |
| Gilead Sciences, INC. | $24.25 | 2019 | |
| Akcea Therapeutics, INC. | $22.55 | 2020 | |
| Atricure, INC. | $22.50 | 2023 | |
| Ethicon US, LLC | $22.45 | 2019 | |
| Angiodynamics, INC. | $20.90 | 2023 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.96 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $17.05 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.77 | 2019 | |
| Tactile Systems Technology INC | $12.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.39 | 2019 | |
| Chiesi USA, INC. | $11.57 | 2019 | |
| Lundbeck LLC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefferson Burroughs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.